Medicines prescribed in England
Which medicines are prescribed most across England, what they cost, and which are growing fastest. Open any medicine to see how its use varies between the 36 integrated care boards.
Latest 12 months: Sep 2025 – Aug 2026, compared with Sep 2024 – Aug 2025. Source: NHSBSA Prescription Cost Analysis.
Items, latest 12 months
1,309,443,452
Prescription items dispensed in the community
Net ingredient cost
£11.95bn
List price, before discounts and fees
Medicines
2,044
BNF chemical substances prescribed
Registered patients
62,878,777
GP registrations, used for rates per 1,000
Top medicines in England
Ranked by items dispensed in the latest 12 months.
| # | Medicine | Items | vs year before | Cost (NIC) | Per 1,000 patients |
|---|---|---|---|---|---|
| 1 | Atorvastatin Lipid-regulating drugs | 79,509,444 | +6.1% | £75.26m | 1,265 |
| 2 | Amlodipine Calcium-channel blockers | 41,560,880 | +3.2% | £36.09m | 661 |
| 3 | Lansoprazole Proton pump inhibitors | 38,173,210 | +3.1% | £43.54m | 607 |
| 4 | Ramipril Renin-angiotensin system drugs | 36,657,165 | +3.1% | £68.31m | 583 |
| 5 | Levothyroxine sodium Thyroid hormones | 35,095,866 | +1.4% | £42.69m | 558 |
| 6 | Omeprazole Proton pump inhibitors | 35,093,015 | −1.9% | £98.89m | 558 |
| 7 | Bisoprolol fumarate Beta-adrenoceptor blocking drugs | 31,653,440 | +3.8% | £44.36m | 503 |
| 8 | Colecalciferol Vitamin D | 29,572,846 | +3.7% | £123.72m | 470 |
| 9 | Metformin hydrochloride Antidiabetic drugs | 27,626,712 | +2.8% | £66.31m | 439 |
| 10 | Sertraline hydrochloride Selective serotonin re-uptake inhibitors | 26,269,633 | +5% | £49.06m | 418 |
| 11 | Aspirin Antiplatelet drugs | 20,283,055 | +0.5% | £42.75m | 323 |
| 12 | Amitriptyline hydrochloride Tricyclic and related antidepressant drugs | 16,660,373 | +2.2% | £18.49m | 265 |
| 13 | Paracetamol Non-opioid analgesics and compound preparations | 15,713,728 | −0.5% | £72.63m | 250 |
| 14 | Salbutamol Adrenoceptor agonists | 15,258,789 | −17.8% | £49.08m | 243 |
| 15 | Co-codamol (Codeine phosphate/paracetamol) Non-opioid analgesics and compound preparations | 14,675,732 | −2.3% | £79.98m | 233 |
| 16 | Losartan potassium Renin-angiotensin system drugs | 14,035,173 | +7.2% | £13.41m | 223 |
| 17 | Mirtazapine Other antidepressant drugs | 14,007,053 | +4.5% | £15.15m | 223 |
| 18 | Influenza Vaccines and antisera | 13,423,046 | +45.5% | £228.81m | 214 |
| 19 | Dapagliflozin Antidiabetic drugs | 13,341,773 | +35.6% | £120.16m | 212 |
| 20 | Citalopram hydrobromide Selective serotonin re-uptake inhibitors | 12,707,469 | −2.4% | £12.10m | 202 |
| 21 | Clopidogrel Antiplatelet drugs | 12,358,884 | +3.4% | £11.84m | 197 |
| 22 | Apixaban Oral anticoagulants | 11,658,500 | +15.6% | £25.69m | 185 |
| 23 | Furosemide Loop diuretics | 11,272,156 | +0.4% | £9.77m | 179 |
| 24 | Emollients Emollients | 11,059,622 | +4.2% | £67.15m | 176 |
| 25 | Other Appliances Other Appliances | 10,694,095 | −2.3% | £61.36m | 170 |
By BNF chapter
| Chapter | Items | Cost (NIC) | Medicines |
|---|---|---|---|
| Cardiovascular System | 397,028,047 | £1.30bn | 168 |
| Central Nervous System | 245,113,381 | £1.70bn | 245 |
| Endocrine System | 150,329,008 | £2.51bn | 142 |
| Gastro-Intestinal System | 121,650,203 | £726.52m | 105 |
| Respiratory System | 74,468,924 | £1.26bn | 83 |
| Nutrition and Blood | 73,698,000 | £977.01m | 441 |
| Appliances | 42,219,084 | £980.47m | 39 |
| Infections | 40,944,887 | £251.67m | 153 |
| Obstetrics, Gynaecology and Urinary-Tract Disorders | 38,252,882 | £318.95m | 70 |
| Musculoskeletal and Joint Diseases | 32,849,481 | £149.27m | 76 |
| Skin | 26,872,187 | £320.20m | 171 |
| Eye | 15,614,640 | £171.88m | 95 |
| Immunological Products and Vaccines | 14,904,135 | £251.45m | 29 |
| Ear, Nose and Oropharynx | 11,921,802 | £93.68m | 70 |
| Stoma Appliances | 8,324,682 | £465.71m | 21 |
| Dressings | 5,126,257 | £179.74m | 15 |
| Malignant Disease and Immunosuppression | 4,796,058 | £183.67m | 69 |
| Incontinence Appliances | 2,895,215 | £72.93m | 13 |
| Anaesthesia | 1,828,852 | £24.11m | 22 |
| Other Drugs and Preparations | 605,691 | £13.59m | 16 |
| Preparations used in Diagnosis | 36 | £7,333 | 1 |
How these figures are made
- England figures, the monthly chart and strengths come from NHS Business Services Authority (NHSBSA) Prescription Cost Analysis, monthly, from January 2021 to Aug 2026. ICB and GP practice figures come from the NHSBSA English Prescribing Dataset, which records the practice that wrote each prescription. We load each month in full and check its totals before publishing it.
- Covers prescriptions dispensed in the community in England: community pharmacies, dispensing doctors, appliance contractors and personally administered items. Medicines supplied in hospital are not included.
- A medicine is a BNF chemical substance (for example atorvastatin), adding up every strength and form. Items are prescription items; cost is net ingredient cost, the list price before discounts and fees.
- Each item is credited to the ICB of the GP practice that prescribed it, wherever it was dispensed, so online pharmacies serving the whole country do not inflate the ICB they are based in. ICB and practice figures add up to about 1% less than England's total, which also counts prescribers outside GP practices. Boards formed by the 2026 mergers add up their predecessors for earlier months, so every year is compared on today's boundaries.
- Growth compares the latest 12 months with the 12 months before. Lists of fastest-growing medicines leave out small numbers (fewer than 10,000 items in England, or 500 in an ICB) so a handful of prescriptions cannot top them.
- Rates per 1,000 patients use the latest NHS Digital count of patients registered with GP practices in each ICB.